Cover Image
Market Research Report

Global Codeine Market Report, History and Forecast 2014-2025, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published by QYResearch Product code 925078
Published Content info 152 Pages
Delivery time: 2-3 business days
Price
Back to Top
Global Codeine Market Report, History and Forecast 2014-2025, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published: February 13, 2020 Content info: 152 Pages
Description

Market Analysis and Insights: Global Codeine Market

In 2018, the global Codeine market size was 334.20 million US$ and it is expected to reach 223.02 million US$ by the end of 2025, with a CAGR of -5.49% between 2019 and 2025.

Global Codeine Scope and Segment

This report studies the Codeine market size by players, regions, product types and end industries, history data 2014-2018 and forecast data 2019-2025; This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

By Company

Taiji

Mallinckrodt

TEVA

Johnson & Johnson

Medreich

Sanofi Aventis

Cipla

Hikma

Pharmaceutical Associates

Novartis

Apotex

Mylan

Aristo Pharma GmbH

Lannett Company

Laboratoire Riva

By Type

      • Single-ingredient Codeine

Multi-ingredient Medications

By Application

Narcotic Analgesic

Antitussive

Others

By Region

      • North America

United States

Canada

Mexico

Asia-Pacific

China

Japan

South Korea

India

Australia

Southeast Asia

      • Europe

Germany

France

UK

Italy

Russia

South America

Brazil

Argentina

Middle East and Africa

Middle East

Africa

Table of Contents

1 CODEINE MARKET OVERVIEW 1

  • 1.1 Codeine Product Overview 1
  • 1.2 Codeine Market Segment by Type 2
    • 1.2.1 Single-ingredient Codeine 3
    • 1.2.2 Multi-ingredient Medications 4
  • 1.3 Global Codeine by Type 5
    • 1.3.1 Global Codeine Sales and Growth by Type 5
    • 1.3.2 Global Codeine Sales Market Share by Type 5
    • 1.3.3 Global Codeine Revenue Market Share by Type 7
    • 1.3.4 Global Codeine Price by Type 8
  • 1.4 North America Codeine by Type 8
  • 1.5 Europe Codeine by Type 9
  • 1.6 Asia-Pacific Codeine by Type 10
  • 1.7 South America Codeine by Type 11
  • 1.8 Middle East and Africa Codeine by Type 12

2 GLOBAL CODEINE MARKET COMPETITION BY COMPANY 14

  • 2.1 Global Codeine Sales Market Share by Company (2018-2019) 14
  • 2.2 Global Codeine Revenue and Share by Company (2018-2019) 16
  • 2.3 Global Codeine Price by Company 18
  • 2.4 Global Top Company Codeine Headquarters and Established Date 19
  • 2.5 Codeine Market Competitive Situation and Trends 19
    • 2.5.1 Codeine Market Concentration Rate 19
    • 2.5.2 Global Codeine Market Share of Top 3 and Top 5 Manufacturers 20
    • 2.5.3 Mergers & Acquisitions, Expansion 20

3 COMPANY PROFILES AND KEY FIGURES IN CODEINE BUSINESS 22

  • 3.1 Taiji 22
    • 3.1.1 Taiji Corporation Information 22
    • 3.1.2 Product Information 23
    • 3.1.3 Taiji Codeine Sales, Revenue and Gross Margin (2018-2019) 23
  • 3.2 Mallinckrodt 24
    • 3.2.1 Mallinckrodt Corporation Information 24
    • 3.2.2 Mallinckrodt Product Information 25
    • 3.2.3 Mallinckrodt Codeine Sales, Revenue and Gross Margin (2018-2019) 25
  • 3.3 TEVA 25
    • 3.3.1 TEVA Corporation Information 25
    • 3.3.2 TEVA Product Information 27
    • 3.3.3 TEVA Codeine Sales, Revenue and Gross Margin (2018-2019) 27
  • 3.4 Johnson & Johnson 27
    • 3.4.1 Johnson & Johnson Corporation Information 27
    • 3.4.2 Johnson & Johnson Product Information 29
    • 3.4.3 Johnson & Johnson Codeine Sales, Revenue and Gross Margin (2018-2019) 29
  • 3.5 Medreich 29
    • 3.5.1 Medreich Corporation Information 29
    • 3.5.2 Medreich Product Information 31
    • 3.5.3 Medreich Codeine Sales, Revenue and Gross Margin (2018-2019) 31
  • 3.6 Sanofi Aventis 31
    • 3.6.1 Sanofi Aventis Corporation Information 31
    • 3.6.2 Sanofi Aventis Product Information 32
    • 3.6.3 Sanofi Aventis Codeine Sales, Revenue and Gross Margin (2018-2019) 32
  • 3.7 Cipla 33
    • 3.7.1 Cipla Corporation Information 33
    • 3.7.2 Cipla Product Information 34
    • 3.7.3 Cipla Codeine Sales, Revenue and Gross Margin (2018-2019) 34
  • 3.8 Hikma 35
    • 3.8.1 Hikma Corporation Information 35
    • 3.8.2 Hikma Product Information 36
    • 3.8.3 Hikma Codeine Sales, Revenue and Gross Margin (2018-2019) 36
  • 3.9 Pharmaceutical Associates 37
    • 3.9.1 Pharmaceutical Associates Corporation Information 37
    • 3.9.2 Pharmaceutical Associates Product Information 38
    • 3.9.3 Pharmaceutical Associates Codeine Sales, Revenue and Gross Margin (2018-2019) 38
  • 3.10 Novartis 39
    • 3.10.1 Novartis Corporation Information 39
    • 3.10.2 Novartis Product Information 40
    • 3.10.3 Novartis Codeine Sales, Revenue and Gross Margin (2018-2019) 40
  • 3.11 Apotex 40
    • 3.11.1 Apotex Corporation Information 40
    • 3.11.2 Apotex Product Information 42
    • 3.11.3 Apotex Codeine Sales, Revenue and Gross Margin (2018-2019) 42
  • 3.12 Mylan 43
    • 3.12.1 Mylan Corporation Information 43
    • 3.12.2 Mylan Product Information 44
    • 3.12.3 Mylan Codeine Sales, Revenue and Gross Margin (2018-2019) 44
  • 3.13 Aristo Pharma GmbH 45
    • 3.13.1 Aristo Pharma GmbH Corporation Information 45
    • 3.13.2 Aristo Pharma GmbH Product Information 46
    • 3.13.3 Aristo Pharma GmbH Codeine Sales, Revenue and Gross Margin (2018-2019) 46
  • 3.14 Lannett Company, Inc. 47
    • 3.14.1 Lannett Company, Inc. Corporation Information 47
    • 3.14.2 Lannett Company, Inc. Product Information 48
    • 3.14.3 Lannett Company, Inc. Codeine Sales, Revenue and Gross Margin (2018-2019) 48
  • 3.15 Laboratoire Riva Inc 49
    • 3.15.1 Laboratoire Riva Inc Corporation Information 49
    • 3.15.2 Laboratoire Riva Inc Product Information 50
    • 3.15.3 Laboratoire Riva Inc Codeine Sales, Revenue and Gross Margin (2018-2019) 50

4 CODEINE STATUS AND OUTLOOK BY REGION 51

  • 4.1 Global Codeine Market Status and Outlook by Region 51
    • 4.1.1 Global Codeine Market Size and CAGR by Region 51
    • 4.1.2 North America 51
    • 4.1.3 Asia-Pacific 52
    • 4.1.4 Europe 53
    • 4.1.5 South America 53
    • 4.1.6 Middle East and Africa 54
  • 4.2 Global Codeine Sales and Revenue by Region 55
    • 4.2.1 Global Codeine Sales Market Share by Region (2014-2019) 55
    • 4.2.2 Global Codeine Revenue Market Share by Region (2014-2019) 56
    • 4.2.3 Global Codeine Sales, Revenue and Price (2014-2019) 58
  • 4.3 North America Codeine Sales, Revenue and Price 59
    • 4.3.1 North America Codeine Sales by Countries 59
    • 4.3.2 United States 60
    • 4.3.3 Canada 61
    • 4.3.4 Mexico 62
  • 4.4 Europe Codeine Sales, Revenue and Price (2014-2019) 63
    • 4.4.1 Europe Codeine Sales by Countries 64
    • 4.4.2 Germany 65
    • 4.4.3 France 66
    • 4.4.4 UK 67
    • 4.4.5 Italy 68
    • 4.4.6 Russia 69
  • 4.5 Asia-Pacific Codeine Sales, Revenue and Price (2014-2019) 70
    • 4.5.1 Asia-Pacific Codeine Sales by Region 70
    • 4.5.2 China 71
    • 4.5.3 Japan 72
    • 4.5.4 South Korea 73
    • 4.5.5 India 74
    • 4.5.6 Australia 75
    • 4.5.7 Southeast Asia 76
  • 4.6 South America Codeine Sales, Revenue and Price (2014-2019) 77
    • 4.6.1 South America Codeine Sales by Region 78
    • 4.6.2 Brazil 79

5 CODEINE BY APPLICATION 80

  • 5.1 Codeine Segment by Application 80
    • 5.1.1 Narcotic Analgesic 80
    • 5.1.2 Antitussive 80
  • 5.2 Global Codeine Product Segment by Application 80
    • 5.2.1 Global Codeine Sales by Application 80
    • 5.2.2 Global Codeine Sales and Market Share by Application (2014-2019) 80
  • 5.3 North America Codeine by Application 81
  • 5.4 Europe Codeine by Application 82
  • 5.5 Asia-Pacific Codeine by Application 83
  • 5.6 South America Codeine by Application 84
  • 5.7 Middle East and Africa Codeine by Application 85

6 GLOBAL CODEINE MARKET FORECAST 87

  • 6.1 Global Codeine Sales, Revenue Forecast (2019-2025) 87
    • 6.1.1 Global Codeine Sales and Growth Rate Forecast (2019-2025) 87
    • 6.1.2 Global Codeine Revenue and Growth Rate Forecast (2019-2025) 88
  • 6.2 Global Codeine Forecast by Region 88
    • 6.2.1 North America Codeine Sales and Revenue Forecast (2019-2025) 89
    • 6.2.2 Europe Codeine Sales and Revenue Forecast (2019-2025) 90
    • 6.2.3 Asia-Pacific Codeine Sales and Revenue Forecast (2019-2025) 91
    • 6.2.4 South America Codeine Sales and Revenue Forecast (2019-2025) 98
    • 6.2.5 Middle East and Africa Codeine Sales and Revenue Forecast (2019-2025) 99
  • 6.3 Codeine Forecast by Type 100
    • 6.3.1 Global Codeine Sales and Revenue Forecast by Type (2019-2025) 100
    • 6.3.2 Single-ingredient Codeine Growth Forecast 102
    • 6.3.3 Multi-ingredient Medications Growth Forecast 102
  • 6.4 Codeine Forecast by Application 103
    • 6.4.1 Global Codeine Sales Forecast by Application (2019-2025) 103
    • 6.4.2 Global Codeine in Narcotic Analgesic Forecast 104
    • 6.4.3 Global Codeine Forecast in Antitussive Forecast 104

7 CODEINE UPSTREAM, OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS 105

  • 7.1 Codeine Key Raw Materials 105
    • 7.1.1 Key Raw Materials 105
    • 7.1.2 Raw Materials Key Suppliers 105
  • 7.2 Proportion of Manufacturing Cost Structure 106
    • 7.2.1 Raw Materials 107
    • 7.2.2 Labor Cost 107
    • 7.2.3 Other Costs Analysis 113
  • 7.3 Codeine Industrial Chain Analysis 118
  • 7.4 Market Opportunities, Challenges, Risks and Influences Factors Analysis 119
    • 7.4.1 Market Opportunities and Drivers 119
    • 7.4.2 Market Challenges 119
    • 7.4.3 Market Risks 120
    • 7.4.4 Porter's Five Forces Analysis 121

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS 122

  • 8.1 Sales Channel 122
  • 8.2 Distributors 123
  • 8.3 Downstream Customers 126

9 RESEARCH FINDINGS AND CONCLUSION 129

10 APPENDIX 130

  • 10.1 Research Methodology 130
    • 10.1.1 Methodology/Research Approach 130
    • 10.1.2 Data Source 133
  • 10.2 Author Details 136
  • 10.3 Disclaimer 136
  • Table 1. Global Codeine Sales and Growth Rate Comparison by Type (M Unit) 5
  • Table 2. Global Codeine Sales by Type (2014-2019) (M Unit) 5
  • Table 3. Global Codeine Sales Share by Type (2014-2019) 5
  • Table 4. Global Codeine Revenue (Million US$) by Type (2014-2019) 7
  • Table 5. Global Codeine Revenue Share by Type (2014-2019) 7
  • Table 6. Global Codeine Price (USD/Unit) by Type (2014-2019) 8
  • Table 7. North America Codeine Sales (M Unit) by Type (2014-2019) 8
  • Table 8. Europe Codeine Sales (M Unit) by Type (2014-2019) 9
  • Table 9. Asia-Pacific Codeine Sales (M Unit) by Type (2014-2019) 10
  • Table 10. South America Codeine Sales (M Unit) by Type (2014-2019) 11
  • Table 11. Middle East and Africa Codeine Sales (M Unit) by Type (2014-2019) 12
  • Table 12. Global Codeine Sales (M Unit) by Company (2018-2019) 14
  • Table 13. Global Codeine Sales Share by Company (2018-2019) 15
  • Table 14. Global Codeine Revenue (Million US$) by Company (2018-2019) 16
  • Table 15. Global Codeine Revenue Share by Company (2018-2019) 17
  • Table 16. Global Market Codeine Average Price (USD/Unit) by Company (2018-2019) 18
  • Table 17. Global Codeine Top Company Headquarters and Established Date 19
  • Table 18. Global Manufacturers Market Concentration Ratio (CR5 and HHI) 20
  • Table 19. Mergers & Acquisitions, Expansion Plans 20
  • Table 20. Taiji Corporation Information 22
  • Table 21. Taiji Codeine Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2019) 23
  • Table 22. Mallinckrodt Corporation Information 24
  • Table 23. Mallinckrodt Codeine Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2019) 25
  • Table 24. TEVA Corporation Information 25
  • Table 25. TEVA Codeine Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2019) 27
  • Table 26. Johnson & Johnson Corporation Information 27
  • Table 27. Johnson & Johnson Codeine Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2019) 29
  • Table 28. Medreich Corporation Information 29
  • Table 29. Medreich Codeine Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2019) 31
  • Table 30. Sanofi Aventis Corporation Information 31
  • Table 31. Sanofi Aventis Codeine Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2019) 32
  • Table 32. Cipla Corporation Information 33
  • Table 33. Cipla Codeine Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2019) 34
  • Table 34. Hikma Corporation Information 35
  • Table 35. Hikma Codeine Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2019) 36
  • Table 36. Pharmaceutical Associates Corporation Information 37
  • Table 37. Pharmaceutical Associates Codeine Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2019) 38
  • Table 38. Novartis Corporation Information 39
  • Table 39. Novartis Codeine Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2019) 40
  • Table 40. Apotex Corporation Information 40
  • Table 41. Apotex Codeine Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2019) 42
  • Table 42. Mylan Corporation Information 43
  • Table 43. Mylan Codeine Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2019) 44
  • Table 44. Aristo Pharma GmbH Corporation Information 45
  • Table 45. Aristo Pharma GmbH Codeine Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2019) 46
  • Table 46. Lannett Company, Inc. Corporation Information 47
  • Table 47. Lannett Company, Inc. Codeine Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2019) 48
  • Table 48. Laboratoire Riva Inc Corporation Information 49
  • Table 49. Laboratoire Riva Inc Codeine Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2019) 50
  • Table 50. Global Codeine Market Size Comparison by Region (2014-2025) (M Unit) & (Million US$) 51
  • Table 51. Global Codeine Sales (M Unit) by Region (2014-2019) 55
  • Table 52. Global Codeine Sales Market Share by Region (2014-2019) 55
  • Table 53. Global Codeine Revenue (Million US$) by Region (2014-2019) 56
  • Table 54. Global Codeine Revenue Market Share by Region (2014-2019) 57
  • Table 55. Global Codeine Sales (M Unit), Revenue (Million US$) and Price (USD/Unit) (2014-2019) 58
  • Table 56. North America Codeine Sales (M Unit), Revenue (Million US$) and Price (USD/Unit) (2014-2019) 59
  • Table 57. North America Codeine Sales by Countries 2014-2019 (M Unit) 59
  • Table 58. Europe Codeine Sales (M Unit), Revenue (Million US$) and Price (USD/Unit) (2014-2019) 63
  • Table 59. Europe Codeine Sales by Countries 2014-2019 (M Unit) 64
  • Table 60. Asia-Pacific Codeine Sales (M Unit), Revenue (Million US$) and Price (USD/Unit) (2014-2019) 70
  • Table 61. Asia-Pacific Codeine Sales by Region (2014-2019) (M Unit) 70
  • Table 62. South America Codeine Sales (M Unit), Revenue (Million US$) and Price (USD/Unit) (2014-2019) 78
  • Table 63. South America Codeine Sales by Region (2014-2019) (M Unit) 78
  • Table 64. Global Codeine Sales (M Unit) Comparison by Application (2019-2025) 80
  • Table 65. Global Codeine Sales (M Unit) by Application (2014-2019) 80
  • Table 66. Global Codeine Sales Share by Application (2014-2019) 81
  • Table 67. North America Codeine Sales (M Unit) by Application (2014-2019) 81
  • Table 68. North America Sales Codeine Market Share by Application (2014-2019) 82
  • Table 69. Europe Codeine Sales (M Unit) by Application (2014-2019) 82
  • Table 70. Asia-Pacific Codeine Sales (M Unit) by Application (2014-2019) 83
  • Table 71. South America Codeine Sales (M Unit) by Application (2014-2019) 84
  • Table 72. Middle East and Africa Codeine Sales (M Unit) by Application (2014-2019) 85
  • Table 73. Global Codeine Sales (M Unit) Forecast by Region (2019-2025) 88
  • Table 74. Global Codeine Sales (M Unit) Forecast by Type (2019-2025) 100
  • Table 75. Global Codeine Revenue (Million US$) Forecast by Type (2019-2025) 101
  • Table 76. Global Codeine Sales (M Unit) Forecast by Application (2019-2025) 103
  • Table 77. Key Raw Materials Lists 105
  • Table 78. Raw Materials Key Suppliers Lists 105
  • Table 79. Manufacturing Cost Structure of Codeine 106
  • Table 80. Average Price of Electricity to Ultimate Customers 2007-2018 113
  • Table 81. China Cost of Electricity 2017 (PER KWH) 116
  • Table 82. Key Opportunities and Drivers: Impact Analysis (2019-2025) 119
  • Table 83. Key Challenges 119
  • Table 84. Distributors List 123
  • Table 85. Codeine Downstream Customers 126
  • Table 86. Research Programs/Design for This Report 130
  • Table 87. Key Data Information from Secondary Sources 133
  • Table 88. Key Data Information from Primary Sources 135
  • Figure 1. Codeine Product Picture 1
  • Figure 2. Global Codeine Revenue (Million US$) Status and Outlook (2014-2025) 2
  • Figure 3. Global Codeine Sales (M Unit) Status and Outlook (2014-2025) 2
  • Figure 4. Product Picture of Single-ingredient Codeine 3
  • Figure 5. Global Single-ingredient Codeine Sales (M Unit) and Growth Rate (2014-2019) 3
  • Figure 6. Product Picture of Multi-ingredient Medications 4
  • Figure 7. Global Multi-ingredient Medications Sales (M Unit) and Growth Rate (2014-2019) 4
  • Figure 8. Global Codeine Sales Market Share by Type (2014-2019) 6
  • Figure 9. Global Codeine Sales Market Share by Type in 2018 6
  • Figure 10. Global Codeine Revenue Share by Type (2014-2019) 7
  • Figure 11. Global Codeine Revenue Market Share by Type in 2018 8
  • Figure 12. North America Codeine Sales Market Share by Type in 2018 9
  • Figure 13. Europe Codeine Sales Market Share by Type in 2018 10
  • Figure 14. Asia-Pacific Codeine Sales Market Share by Type in 2018 11
  • Figure 15. South America Codeine Sales Market Share by Type in 2018 12
  • Figure 16. Middle East and Africa Codeine Sales Market Share by Type in 2018 13
  • Figure 17. Global Codeine Sales Share by Company in 2018 16
  • Figure 18. Global Codeine Revenue Share by Company in 2018 18
  • Figure 19. Codeine Market Share of Top 3 and Top 5 Manufacturers 20
  • Figure 20. Codeine Product Information of Taiji 23
  • Figure 21. Mallinckrodt Codeine Product Information 25
  • Figure 22. TEVA Codeine Product Information 27
  • Figure 23. Johnson & Johnson Codeine Product Information 29
  • Figure 24. Medreich Codeine Product Information 31
  • Figure 25. Sanofi Aventis Codeine Product Information 32
  • Figure 26. Cipla Codeine Product Information 34
  • Figure 27. Hikma Codeine Product Information 36
  • Figure 28. Pharmaceutical Associates Codeine Product Information 38
  • Figure 29. Novartis Codeine Product Information 40
  • Figure 30. Apotex Codeine Product Information 42
  • Figure 31. Mylan Codeine Product Information 44
  • Figure 32. Aristo Pharma GmbH Codeine Product Information 46
  • Figure 33. Lannett Company, Inc. Codeine Product Information 48
  • Figure 34. Laboratoire Riva Inc Codeine Product Information 50
  • Figure 35. North America Codeine Revenue (Million US$) and Growth Rate (2014-2025) 52
  • Figure 36. Asia-Pacific Codeine Revenue (Million US$) and Growth Rate (2014-2025) 52
  • Figure 37. Europe Codeine Revenue (Million US$) and Growth Rate (2014-2025) 53
  • Figure 38. South America Codeine Revenue (Million US$) and Growth Rate (2014-2025) 54
  • Figure 39. Middle East and Africa Codeine Revenue (Million US$) and Growth Rate (2014-2025) 54
  • Figure 40. Global Codeine Sales Market Share by Region (2014-2019) 56
  • Figure 41. 2018 Global Codeine Sales Market Share by Region 56
  • Figure 42. Global Codeine Revenue Market Share by Region (2014-2019) 57
  • Figure 43. 2018 Global Codeine Revenue Market Share by Region 58
  • Figure 44. North America Codeine Sales Growth Rate (M Unit) 59
  • Figure 45. North America Codeine Sales Share by Countries 2018 60
  • Figure 46. United States Codeine Sales (M Unit) (2014-2019) 60
  • Figure 47. United States Codeine Revenue (Million US$) (2014-2019) 61
  • Figure 48. Canada Codeine Sales (M Unit) (2014-2019) 61
  • Figure 49. Canada Codeine Revenue (Million US$) (2014-2019) 62
  • Figure 50. Mexico Codeine Sales (M Unit) (2014-2019) 62
  • Figure 51. Mexico Codeine Revenue (Million US$) (2014-2019) 63
  • Figure 52. Europe Codeine Sales Growth Rate (M Unit) 63
  • Figure 53. Europe Codeine Sales Share by Countries 2018 64
  • Figure 54. Germany Codeine Sales (M Unit) (2014-2019) 65
  • Figure 55. Germany Codeine Revenue (Million US$) (2014-2019) 65
  • Figure 56. France Codeine Sales (M Unit) (2014-2019) 66
  • Figure 57. France Codeine Revenue (Million US$) (2014-2019) 66
  • Figure 58. UK Codeine Sales (M Unit) (2014-2019) 67
  • Figure 59. UK Codeine Revenue (Million US$) (2014-2019) 67
  • Figure 60. Italy Codeine Sales (M Unit) (2014-2019) 68
  • Figure 61. Italy Codeine Revenue (Million US$) (2014-2019) 68
  • Figure 62. Russia Codeine Sales (M Unit) (2014-2019) 69
  • Figure 63. Russia Codeine Revenue (Million US$) (2014-2019) 69
  • Figure 64. Asia-Pacific Codeine Sales Growth Rate (M Unit) 70
  • Figure 65. Asia-Pacific Codeine Sales Share by Region in 2018 71
  • Figure 66. China Codeine Sales (M Unit) (2014-2019) 71
  • Figure 67. China Codeine Revenue (Million US$) (2014-2019) 72
  • Figure 68. Japan Codeine Sales (M Unit) (2014-2019) 72
  • Figure 69. Japan Codeine Revenue (Million US$) (2014-2019) 73
  • Figure 70. South Korea Codeine Sales (M Unit) (2014-2019) 73
  • Figure 71. South Korea Codeine Revenue (Million US$) (2014-2019) 74
  • Figure 72. India Codeine Sales (M Unit) (2014-2019) 74
  • Figure 73. India Codeine Revenue (Million US$) (2014-2019) 75
  • Figure 74. Australia Codeine Sales (M Unit) (2014-2019) 75
  • Figure 75. Australia Codeine Revenue (Million US$) (2014-2019) 76
  • Figure 76. Southeast Asia Codeine Sales (M Unit) (2014-2019) 76
  • Figure 77. Southeast Asia Codeine Revenue (Million US$) (2014-2019) 77
  • Figure 78. South America Codeine Sales Growth Rate (M Unit) 77
  • Figure 79. South America Codeine Sales Share by Region 2018 78
  • Figure 80. Brazil Codeine Sales (M Unit) (2014-2019) 79
  • Figure 81. Brazil Codeine Revenue (Million US$) (2014-2019) 79
  • Figure 82. Global Sales Codeine Market Share by Application in 2018 81
  • Figure 83. North America Sales Codeine Market Share by Application in 2018 82
  • Figure 84. Europe Sales Codeine Market Share by Application in 2018 83
  • Figure 85. Asia-Pacific Sales Codeine Market Share by Application in 2018 84
  • Figure 86. South America Sales Codeine Market Share by Application in 2018 85
  • Figure 87. Middle East and Africa Sales Codeine Market Share by Application in 2018 86
  • Figure 88. Global Codeine Sales (M Unit) and Growth Rate Forecast (2019-2025) 87
  • Figure 89. Global Codeine Revenue (Million US$) and Growth Rate Forecast (2019-2025) 88
  • Figure 90. Global Codeine Sales Market Share Forecast by Region (2019-2025) 89
  • Figure 91. North America Codeine Sales (M Unit) and Growth Rate Forecast (2019-2025) 89
  • Figure 92. North America Codeine Revenue and Growth Rate Forecast (2019-2025) (Million US$) 90
  • Figure 93. Europe Codeine Sales (M Unit) and Growth Rate Forecast (2019-2025) 90
  • Figure 94. Europe Codeine Revenue and Growth Rate Forecast (2019-2025) (Million US$) 91
  • Figure 95. Asia-Pacific Codeine Sales (M Unit) and Growth Rate Forecast (2019-2025) 91
  • Figure 96. Asia-Pacific Codeine Revenue and Growth Rate Forecast (2019-2025) (Million US$) 92
  • Figure 97. China Codeine Sales (M Unit) and Growth Rate Forecast (2019-2025) 92
  • Figure 98. China Codeine Revenue and Growth Rate Forecast (2019-2025) (Million US$) 93
  • Figure 99. Japan Codeine Sales (M Unit) and Growth Rate Forecast (2019-2025) 93
  • Figure 100. Japan Codeine Revenue and Growth Rate Forecast (2019-2025) (Million US$) 94
  • Figure 101. South Korea Codeine Sales (M Unit) and Growth Rate Forecast (2019-2025) 94
  • Figure 102. South Korea Codeine Revenue and Growth Rate Forecast (2019-2025) (Million US$) 95
  • Figure 103. India Codeine Sales (M Unit) and Growth Rate Forecast (2019-2025) 95
  • Figure 104. India Codeine Revenue and Growth Rate Forecast (2019-2025) (Million US$) 96
  • Figure 105. Australia Codeine Sales (M Unit) and Growth Rate Forecast (2019-2025) 96
  • Figure 106. Australia Codeine Revenue and Growth Rate Forecast (2019-2025) (Million US$) 97
  • Figure 107. Southeast Asia Codeine Sales (M Unit) and Growth Rate Forecast (2019-2025) 97
  • Figure 108. Southeast Asia Codeine Revenue and Growth Rate Forecast (2019-2025) (Million US$) 98
  • Figure 109. South America Codeine Sales (M Unit) and Growth Rate Forecast (2019-2025) 98
  • Figure 110. South America Codeine Revenue and Growth Rate Forecast (2019-2025) (Million US$) 99
  • Figure 111. Middle East and Africa Codeine Sales (M Unit) and Growth Rate Forecast (2019-2025) 99
  • Figure 112. Middle East and Africa Codeine Revenue and Growth Rate Forecast (2019-2025) (Million US$) 100
  • Figure 113. Global Codeine Sales Market Share Forecast by Type (2019-2025) 101
  • Figure 114. Global Codeine Revenue Market Share Forecast by Type (2019-2025) 101
  • Figure 115. Single-ingredient Codeine Sales (M Unit) Growth Forecast 102
  • Figure 116. Multi-ingredient Medications Sales Growth Forecast 102
  • Figure 117. Global Codeine Sales Forecast by Application (2019-2025) 103
  • Figure 118. Global Codeine Sales (M Unit) in Narcotic Analgesic Forecast 104
  • Figure 119. Global Codeine Sales (M Unit) in Antitussive Forecast 104
  • Figure 120. USA Labor Cost Analysis 2015-2018 107
  • Figure 121. Cost of Employing a Factory Worker 108
  • Figure 122. Europe Labor Cost Analysis 2015-2018 109
  • Figure 123. Germany Labor Cost Analysis 2015-2018 109
  • Figure 124. UK Labor Cost Analysis 2015-2018 110
  • Figure 125. France Labor Cost Analysis 2015-2018 110
  • Figure 126. Italy Labor Cost Analysis 2015-2018 110
  • Figure 127. Monthly Minimum Wages in Asia 2016 111
  • Figure 128. China Labor Costs 2015-2018 111
  • Figure 129. Japan Average Monthly Wages 2015-2018 112
  • Figure 130. Global Electricity Prices by Select Countries in 2017 (in U.S. Dollars per Kilowatt Hour) 113
  • Figure 131. Electricity Prices for Household Consumers in 2017 115
  • Figure 132. Codeine Industrial Chain Analysis 118
  • Figure 133. US Overdose Deaths Involving Opioids. Deaths per 100,000 Populations by Year. 120
  • Figure 134. Drugs Involved in USA Overdose Deaths, 1999 to 2017 120
  • Figure 135. Porter's Five Forces Analysis 121
  • Figure 136. Channels of Distribution 123
  • Figure 137. Distributors Profiles 125
  • Figure 138. Bottom-up and Top-down Approaches for This Report 132
  • Figure 139. Data Triangulation 133
  • Figure 140. Key Executives Interviewed 135
Back to Top